120 W Greenlight HPS Laser Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia in Men with Detrusor Underactivity.
10.4111/kju.2011.52.12.824
- Author:
Sae Woong CHOI
1
;
Yong Sun CHOI
;
Woong Jin BAE
;
Su Jin KIM
;
Hyuk Jin CHO
;
Sung Hoo HONG
;
Ji Youl LEE
;
Tae Kon HWANG
;
Sae Woong KIM
Author Information
1. Department of Urology, Seoul St.Mary's Hospital, Seoul, Korea. ksw1227@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Bladder dysfunction;
Laser therapy;
Prostatic hyperplasia
- MeSH:
Humans;
Laser Therapy;
Lower Urinary Tract Symptoms;
Male;
Prostate;
Prostatic Hyperplasia;
Urinary Bladder Neck Obstruction;
Urodynamics;
Volatilization
- From:Korean Journal of Urology
2011;52(12):824-828
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Most men with benign prostatic hyperplasia (BPH) have bothersome lower urinary tract symptoms (LUTS). This study aimed to investigate the safety and efficacy of high-performance system (HPS) laser photoselective vaporization of the prostate (PVP) for the treatment of BPH in men with detrusor underactivity (DU). MATERIALS AND METHODS: From March 2009, 371 patients with BPH were divided into 2 groups according to the findings of preoperative urodynamic study: 239 (64.4%) patients with bladder outlet obstruction (BOO) and 132 (35.6%) patients with bladder outlet obstruction with detrusor underactivity (BOO+DU). 120 W HPS laser PVP was performed to resolve the BOO. The perioperative data and postoperative results at 1 month and 12 months, including the International Prostate Symptom Score (IPSS), maximum urinary flow (Qmax), and postvoid residual urine (PVR) values, were evaluated. RESULTS: Compared with the preoperative parameters, significant improvements in IPSS, Qmax, and PVR were observed in each group at 1 and 12 months after the operation. In addition, IPSS, Qmax, and PVR were not significantly different between the BOO and BOO+DU groups at 1 and 12 months after the operation. CONCLUSIONS: Surgery to relieve BOO in the patients with BPH seems to be an appropriate treatment modality regardless of the existence of DU.